December 22, 2023 Comments Off on New tentative approval for Teva Pharms drug dasatinib Posted in: Tentative Approval Dasatinib is the generic ingredient in two branded drugs marketed by Apotex and Bristol Myers Squibb and is included in three NDAs. There are two patents protecting this compound. Drug…
The post New tentative approval for Teva Pharms drug dasatinib app…
December 22, 2023 Comments Off on New patent for Kaleo Inc drug AUVI-Q Posted in: Patent Added Annual Drug Patent Expirations for AUVI-Q Auvi-q is a drug marketed by Kaleo Inc and is included in one NDA. It is available from three suppliers. There are thirty-one patents…
The post New patent for Kaleo Inc drug AUVI-Q appeared first on DrugPatentW…